Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 4.56% | 58.07 | 0.0% | $1728.62m | |
| GILD | Gilead Sciences, Inc. | -0.25% | 75.13 | 1.0% | $1315.09m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.78% | 582.73 | 2.5% | $968.87m | |
| AMGN | Amgen, Inc. | 0.07% | 224.28 | 1.3% | $646.77m | |
| NVAX | Novavax, Inc. | 1.09% | 45.33 | 102.0% | $586.06m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.11% | 277.70 | 1.9% | $545.33m | |
| BIIB | Biogen, Inc. | 0.21% | 301.13 | 1.6% | $411.26m | |
| ILMN | Illumina, Inc. | -1.89% | 365.97 | 3.5% | $381.84m | |
| SRNE | Sorrento Therapeutics, Inc. | -0.30% | 4.94 | 1.8% | $297.10m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.11% | 115.70 | 2.0% | $268.02m | |
| SGEN | Seattle Genetics, Inc. | 0.44% | 152.22 | 6.1% | $255.63m | |
| A | Agilent Technologies, Inc. | 0.72% | 87.31 | 1.6% | $200.94m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.75% | 104.81 | 4.3% | $178.43m | |
| CODX | Co-Diagnostics, Inc. | -0.83% | 17.32 | 0.0% | $169.39m | |
| INCY | Incyte Corp. | -0.53% | 100.02 | 2.5% | $156.66m |
Company Profile
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.